Why Massage and Acupuncture Relief Wears Off: A Doctor Explains

You leave your Monday afternoon bodywork session floating on air. Whether you spent an hour on an acupuncture table with needles quietly resetting your meridians or underwent deep myofascial release with a skilled massage therapist, the transformation feels undeniable. Your shoulders have dropped two inches from your ears, your lower back moves without that familiar sharp catch, and you can turn your neck to check your blind spot without wincing.

You pay your copay or out-of-pocket fee, step out into the evening air, and think: Finally, my body is turning a corner.

Then Wednesday morning arrives.

You roll out of bed, and by the time you reach the kitchen for your first cup of coffee, the old heaviness has settled right back into your upper trapezius. The dull ache across your sacrum has returned. By Thursday afternoon, you feel just as tight, restricted, and guarded as you did before the treatment began. You find yourself trapped in an exhausting, expensive cycle: paying for temporary relief that evaporates almost as soon as you settle back into your life.

Most patients blame themselves. They assume they sat poorly at their desk, slept in an awkward position, or have muscles that are simply stubborn and broken. But what you are experiencing is not a failure of willpower or poor posture. It is a predictable neurological rebound rooted in a biological gap that manual therapy cannot fix on its own: your baseline endocannabinoid tone.

The Forty-Eight Hour Flash: The Science of the “Massage High”

To understand why manual therapy relief disappears so quickly, we first have to understand why it feels so incredible in the first place.

When an acupuncturist places a needle into a myofascial trigger point or a massage therapist shears through a dense layer of thoracolumbar fascia, they are not just loosening mechanical fibers. They are triggering a profound cascade of cellular signaling called mechanotransduction.

Mechanical pressure on fibroblasts and sensory nerve endings stimulates the immediate release of endogenous neurotransmitters. For decades, conventional medicine attributed this relief entirely to endorphins. But rigorous research has revealed a much more important player: the endocannabinoid system (ECS).

In groundbreaking clinical trials, researchers measured circulating blood levels of endocannabinoids before and after manual manipulative therapy. The findings were striking: deep tissue manipulation and spinal mobilization trigger an immediate, significant surge in circulating anandamide, the body’s natural cannabinoid that binds to CB1 and CB2 receptors. This anandamide surge is what delivers the blissful sense of tranquility, systemic vascular dilation, and acute pain relief you feel when you step off the table.

The Neuromuscular Spindle Trap: Why Muscles Retighten

While enzymes are clearing your natural cannabinoid surge, a secondary neurological mechanism is quietly pulling your tissues back into spasm: the muscle spindle reflex.

Every skeletal muscle in your body contains sensory stretch receptors called muscle spindles, regulated by gamma-motor neurons in the spinal cord. In chronic pain, whether from an old injury, postural stress, or the systemic connective tissue shifts seen in perimenopausal joint and fascial aches, your nervous system adopts a protective posture known as muscle guarding.

The spinal cord keeps the gamma-motor neuron gain turned all the way up. When a therapist manually stretches and kneads the muscle, they force the mechanical fibers to lengthen. But because the central nervous system still perceives the area as vulnerable or injured, it continues to broadcast danger signals. As soon as the temporary anandamide and endorphin dampening wears off, the hyperactive muscle spindles fire rapidly, snapping the tissue back to its shortened, guarded baseline.

You cannot mechanically stretch your way out of a central neurological guarding reflex. You have to quiet the alarm at the receptor level.

Clinical Endocannabinoid Deficiency in Chronic Pain

This cycle of rapid rebound is one of the classic clinical indicators of what Dr. Ethan Russo identified as Clinical Endocannabinoid Deficiency (CECD).

Under healthy conditions, your endocannabinoid system acts as an ongoing biological shock absorber. It maintains tonic inhibition over glutamate (the primary excitatory neurotransmitter) and substance P (a primary pain-transmitting peptide) in the dorsal horn of the spinal cord. When you undergo bodywork, a healthy ECS maintains that lowered pain threshold for days or weeks, allowing the fascia to remodel in its elongated state.

In patients with CECD, however, baseline endocannabinoid tone is depleted. Receptors are starved for stimulation, and sensory nerves remain permanently sensitized. Manual therapies provide a brief mechanical reprieve, but without internal chemical support, the relief cannot anchor.

A Physician’s Synergy Protocol: How to Lock In Your Bodywork

Instead of continuing the cycle of temporary relief, we can use plant-derived cannabinoids to create a supportive biochemical bridge before and after your sessions. In my clinical practice, we pair bodywork with a targeted three-step protocol:

Transforming Temporary Comfort Into Lasting Health

Acupuncture, massage, and physical medicine are extraordinary tools for restoring human mobility. But expecting a one-hour weekly session to overcome 167 hours of baseline neurological guarding is an unfair expectation for both you and your therapist.

When you support your tissues with the biochemical building blocks they need to sustain parasympathetic calm, bodywork ceases to be an endless game of catch-up. Your adjustments hold. Your fascia softens permanently. And the relief you feel on Monday stays with you long into the following week.

Frequently Asked Questions

Academic and Clinical References

1. Degenhardt, B. F., et al. (2014). “Role of osteopathic manipulative treatment in altering pain biomarkers: a randomized controlled trial.” Journal of the American Osteopathic Association, 114(7), 538-548. DOI: 10.7556/jaoa.2014.136.
2. McPartland, J. M. (2016). “The endocannabinoid system, an osteopathic perspective.” Cannabis and Cannabinoid Research, 1(1), 192-200. DOI: 10.1089/can.2016.0028.
3. Langevin, H. M., et al. (2011). “Fibroblast cytoskeletal remodeling contributes to connective tissue tension.” Manual Therapy, 16(4), 399-403. DOI: 10.1016/j.math.2011.02.003.
4. Russo, E. B. (2016). “Clinical endocannabinoid deficiency reconsidered: current research supports the theory in migraine, fibromyalgia, irritable bowel, and other treatment-resistant syndromes.” Cannabis and Cannabinoid Research, 1(1), 154-165. DOI: 10.1089/can.2016.0009.